Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisuride add-on subcutaneous infusion in pulmonary arterial hypertension
2012-001675-37Phase 2Terminated
- Sponsor
- Sinoxa Pharma
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisuride in pulmonary arterial hypertension (PAH), sponsored by Sinoxa Pharma. Started May 2012; status: terminated.
02
Drugs
lisuride
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2012-001675-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001675-37.